Tag #Non-Hodgkin Lymphoma

Showing 1 to 1 of 1 results

politico.eu
🌐 85% Global Worthiness
News related image

CAR T-Cell Therapy for NHL: Addressing Access Barriers and System Readiness in Europe

Non-Hodgkin lymphoma (NHL) constitutes a major health challenge in Europe, with annual productivity losses estimated at €110.7 million; CAR T-cell therapy offers a promising but resource-intensive treatment option that requires policy changes for equitable access.

Progress

48% Bias Score

Good Health and Well-being

Showing 1 to 1 of 1 results